In Brief: Vasomedical Inc.
This article was originally published in The Gray Sheet
Executive Summary
Vasomedical Inc.: Results of a 50-patient study of Enhanced External Counterpulsation (EECP) technology -- "a non-surgical therapy intended to reduce or eliminate symptoms of patients suffering from chronic stable angina pectoris" -- show that all patients receiving the treatment reported a decrease in anginal symptoms, researchers report in the May issue of The American Journal of Cardiology. Investigators William Lawson, MD, et. al., State University of New York at Stony Brook, say EECP facilitates blood flow through coronary collatorals by aiding the development of new collatorals or by enhancing flow through existing collatorals. The study also reports that 95% of patients with blockage of one vessel, 90% of patients with dual vessel blockage and 43% with triple blockage, experienced improvement post-treatment...